About: LY-215,840

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

LY-215,840 is an ergoline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.

Property	Value
dbo:abstract	LY-215,840 is an ergoline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies. (en)
dbo:casNumber	137328-52-0
dbo:fdaUniiCode	D2G5U4P5B3
dbo:pubchem	9822062
dbo:thumbnail	wiki-commons:Special:FilePath/LY-215840_structure.png?width=300
dbo:wikiPageID	40779001 (xsd:integer)
dbo:wikiPageLength	5071 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1108125874 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Hypertension dbc:Cyclopentanes dbr:Eli_Lilly_and_Company dbr:Muscle_relaxant dbc:Ergolines dbr:5-HT2_receptor dbr:5-HT7_receptor dbr:Ergoline dbr:Receptor_(biochemistry) dbc:Eli_Lilly_and_Company_brands dbc:5-HT2_antagonists dbr:Serotonin dbr:Antagonist_(pharmacology)
dbp:c	24 (xsd:integer)
dbp:casNumber	137328 (xsd:integer)
dbp:chemspiderid	7997811 (xsd:integer)
dbp:h	33 (xsd:integer)
dbp:iupacName	-N--4-isopropyl-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide (en)
dbp:iupharLigand	180 (xsd:integer)
dbp:n	3 (xsd:integer)
dbp:o	2 (xsd:integer)
dbp:pubchem	9822062 (xsd:integer)
dbp:smiles	CN1[C@]CC4=CNC5=CC=CC2=C54 (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	IMSDOBUYDTVEHN-ILMFXRJHSA-N (en)
dbp:unii	D2G5U4P5B3 (en)
dbp:width	220 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Drugbox dbt:Nervous-system-drug-stub dbt:Reflist dbt:Serotonin_receptor_modulators dbt:Short_description dbt:Cascite dbt:Fdacite dbt:Ergolines
dct:subject	dbc:Cyclopentanes dbc:Ergolines dbc:Eli_Lilly_and_Company_brands dbc:5-HT2_antagonists
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Adversary109773245 yago:CausalAgent100007347 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo dbo:Drug yago:Whole100003553 yago:Wikicat5-HT2Antagonists
rdfs:comment	LY-215,840 is an ergoline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies. (en)
rdfs:label	LY-215,840 (en)
owl:sameAs	freebase:LY-215,840 yago-res:LY-215,840 wikidata:LY-215,840 dbpedia-sh:LY-215,840 dbpedia-sr:LY-215,840 https://global.dbpedia.org/id/YaPU
prov:wasDerivedFrom	wikipedia-en:LY-215,840?oldid=1108125874&ns=0
foaf:depiction	wiki-commons:Special:FilePath/LY-215840_structure.png
foaf:isPrimaryTopicOf	wikipedia-en:LY-215,840
is dbo:wikiPageRedirects of	dbr:LY-215840 dbr:LY215840 dbr:LY_215840
is dbo:wikiPageWikiLink of	dbr:5-HT7_receptor dbr:C24H33N3O2 dbr:LY-215840 dbr:LY215840 dbr:LY_215840
is foaf:primaryTopic of	wikipedia-en:LY-215,840

This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License